The European Union could lose €2 billion of investment a year in medicines research and development if a law overhauling the bloc’s pharmaceutical regime goes ahead, an industry group warned Monday.
The European Commission has said it wants to shorten the standard period of patent protection for new medicines from eight to six years, as part of a wider plan to ensure affordable access to drugs and boost innovation.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Entertainment & Media industry to grow by 3.6% a yearThe Irish entertainment and media industry is to grow by an annual compound rate of 3.6% between now and 2027, a new report from PwC has predicted.
Leer más »